Cancer Weekly articles from May 2004

Cancer Weekly archives from May 2004

Sentinel node biopsy should be standardized.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Researchers urge standardization of sentinel node biopsy (SNB) and pathological examination, in order to improve diagnostic and therapeutic strategies for breast and gastrointestinal cancer patients....

Updated nausea and vomiting treatment guidelines offered to cancer patients.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- The National Comprehensive Cancer Network (NCCN) and the American Cancer Society collaborated to update Nausea and Vomiting Treatment Guidelines for Patients with Cancer. This title is one of a...

There may be a link between Internet use and cancer outcomes.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Research identifies that a high percentage of cancer patients use the internet for a variety of reasons related to their disease. According to recent research published in the Ca - A Cancer Journal...

Researchers develop polarized reflectance spectroscopy for precancer detection.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- A new noninvasive optical technique can potentially detect early precancers, thereby improving greater survival and patient quality of life, researchers report. "Early detection of cancer and its...

Oncogenesis from single base mutation in IRES of Epstein-Barr nuclear antigen 1.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Oncogenesis develops from a single base mutation in the internal ribosome entry site of Epstein-Barr nuclear antigen 1. Recently published data show that "the U leader exon located within the 5'...

Molecular analyses of ALL suggest strategies for more effective treatments.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- The cure rate for pediatric acute lymphoblastic leukemia (ALL) might continue to rise with improved use of conventional therapies. But even more effective and less toxic therapies based on genetic...

AACR data indicate strong synergy of Hsp90 inhibitor, 17-AAG.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Kosan Biosciences (KOSN) announced, at the American Association for Cancer Research, preclinical in vitro data on the cytotoxic and antiproliferative effects of Kosan's lead Hsp90 inhibitor, 17-AAG,...

CLEAR II registry launched.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Enzon Pharmaceuticals, Inc., (ENZN) announced a major new initiative to build upon the value of its CLEAR (Collaborative Exchange of Antifungal Research) patient registry with the launch of CLEAR II....

EGCG inhibits radiation-induced apoptosis by inactivating capase pathway.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Polyphenol EGCG inhibits radiation-induced apoptosis by inactivating the capase pathway in HaCaT cells. "Green tea is a rich source of polyphenols, and (-)-epigallocatechin-3-gallate (EGCG) is a...

FGFR3 and P53 are often seen in bladder cancer.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Factor growth receptor 3 and P53 mutation may be two separate genetic pathways in the pathogenesis of bladder cancer, researchers say. According to published research from Netherlands, "Fibroblast...

Prognostic model applied to superficial bladder cancer.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Scientists have constructed and validated a prognostic model across several studies, with an application in superficial bladder cancer. "Many models for clinical prediction (prognosis or diagnosis)...

Cognitive function can decline in patients with brain tumors.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Declining cognitive function is often the sign of progressive disease, researchers say. "Cognitive function, with survival and response on brain imaging, is increasingly regarded as an important...

Proton magnetic resonance spectroscopy can monitor glioma response to treatment.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Monitoring low-grade glioma response to temozolomide can be accomplished using proton magnetic resonance spectroscopy (H-1-MRS), researchers say. "Assessment of low-grade glioma treatment response...

Aromatase inhibitors may replace tamoxifen.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- A 4-year update of the ATAC (Arimidex, Tamoxifen Alone or in Combination) Trial showed that patients on anastrozole have longer disease-free survival, lower incidence of contralateral breast cancer, and...

Breast cancer patients self-participation depends on length of consultation.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Study finds that patient-physician communication interactions can be evaluated by perceptual and behavioral measures. "This study examines correlations between observable communicative behaviors...

CXCR4 expressed in DCIS of the breast and atypical ductal hyperplasia.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- CXCR4 is expressed in DCIS of the breast and atypical ductal hyperplasia, and may play a key role in the development of these malignancies. "Recent evidence attributed important influence to...

Certain characteristics of tumor in vessels and lymph nodes predict progression.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Certain characteristics of tumor in vessels and lymph nodes predict progression. According to published research from Japan, "Invasive ductal carcinomas of the breast are composed of primary...

Drug development company doses first patient in breast cancer study.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- YM BioSciences Inc. (YM) announced that the first patient has been dosed in its 700-patient phase III registration trial for metastatic breast cancer. The international pivotal trial is designed to...

Frozen section and permanent analysis of sentinel nodes are equivalent.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Using frozen section (FS) or permanent section (PS) analysis of sentinel node biopsies in breast cancer does not affect patient quality of life, researchers report. According to published research...

HCCR-2 related to breast cancer development and p53 tumor suppressor regulation.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Oncoprotein HCCR-2 is related to breast cancer development and p53 tumor suppressor regulation. "Transgenic mice containing novel oncogene HCCR-2 were generated to analyze the phenotype and to...

Locoregional recurrence is lower in recent years after breast-conserving surgery.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Improved patient selection may be partly responsible for lower rates of recurrence after breast-conserving surgery, researchers say. "The aim of our study was to compare the locoregional recurrence...

Lymphatic mapping suggested when invasive breast cancer is suspected.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Lymphatic mapping is suggested any time invasive breast cancer in suspected. "The concept of lymphatic mapping has helped to redefine the clinical significance of lymph nodes with respect to breast...

Malignant breast cancer cells revert to normal with manipulation.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Manipulation of the extracellular matrix of non-malignant breast cells can lead to genomic instability via oxidative damage, study findings show. The extracellular matrix (ECM) is a network of...

Million Women Study: Hormone replacement therapy increases breast cancer risk.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Researchers believe the increased risk of invasive breast cancer as reported in the Million Women Study (MWS) was was not justifiable. "MWS published in the summer of 2003, has suggested unexpected...

New reimbursement codes announced for MammoSite balloon catheter.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Proxima Therapeutics, Inc., announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has assigned new Healthcare Common Procedure Coding System (HCPCS) codes for placement of its...

Perillyl alcohol inhibits human breast cancer cell growth in mice.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Researchers report that monoterpene perillyl alcohol (POH) administered to nude mice inhibited breast cancer cell growth. According to a study from Japan, "The effect of POH on cell growth, cell...

Progenta breast cancer treatment data presented at cancer research meeting.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Zonagen, Inc., (ZONA) announced that data generated at Zonagen in collaboration with scientists at the University of Illinois-Chicago that indicate the potential for Progenta for the treatment of breast...

Sentinel node biopsy in breast cancer patients avoids axillary dissection.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Sentinel node biopsy in breast cancer patients avoids axillary dissection. According to recent research from Netherlands, "Since its introduction in the early 1990s, the sentinel node (SN) concept...

Stromal infiltration may predict tumor invasion in breast FNA biopsy.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Stromal infiltration may predict tumor invasion in breast fine-needle aspiration biopsy. According to a study from the United States, "Clinical management of in situ carcinoma of the breast is...

Studies: INGN 241 enhances antitumor effects of Herceptin.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Preclinical data presented at the 95th annual meeting of the American Association of Cancer Research demonstrate that INGN 241 enhances the antitumor effects of Herceptin (Trastuzumab) in HER2-positive...

Study shows there's a learning curve in performing sentinel node biopsy.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Proctored training of surgeons learning to perform sentinel node biopsy results in acceptable skills after performing 40 procedures, study finds. According to recent research published in the...

Treatment based on radar research is in final stage of clinical testing.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- A breast cancer treatment based on Massachusetts Institute of Technology (MIT) radar research that was originally aimed at detecting space-borne missiles is showing promise in the final phase of...

Ultrasound is effective in evaluating the mastectomy site.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Ultrasonography (US) is the most effective modality for evaluating the structures at the site of mastectomy, researchers report. According to published research from the United States, "Evaluation...

Implications of estrogen receptor beta in breast cancer outlined.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- The implications of the estrogen receptor beta for patients with breast cancer are outlined in a recent issue of Lancet Oncology. "Estrogen receptor (ER) a is a well established prognostic marker...

Stromal composition helps diagnosis of biphasic lesions of the breast.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Phyllodes tumor is a possibility when a biphasic breast tumor has cellular stroma, researchers report. According to recent research from the United States, "Biphasic lesions of the breast are...

Conclusion of joint venture relationship announced.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Targeted Genetics Corporation (TGEN) announced an agreement with Elan Corporation, plc, (ELN) that formally concludes the collaboration between the companies through the joint venture, Emerald Gene...

Precision Vascular Systems acquired by device maker; Sentinol launched.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Boston Scientific Corporation (BSX) announced that it has acquired Precision Vascular Systems, Inc., (Precision Vascular), a privately held company located in West Valley City, Utah, and that it has...

NeoRx sells Pretarget intellectual property, announces resignation of VP.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- NeoRx Corp. (NERX), a cancer therapeutics development company, announced that it has executed an agreement with privately held Aletheon Pharmaceuticals, Inc., for the sale and transfer of NeoRx's...

3-D agarose matrix used to determine mechanism of cell death by COX-2 inhibitor.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- A 3-dimensional agarose matrix was used to determine the mechanism of cell death by COX-2 inhibitor etodolac. A new method "for studying slow acting pharmaceutical COX-2 inhibitors in the MCF-7...

Drug discovery systems manufacturer announces FDA meeting results.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Ventana Medical Systems, Inc., (VMSI) announced that it has met with the U.S. Food and Drug Administration Office of In Vitro Diagnostic Evaluation and Safety (OIVD) to discuss the letter Ventana...

Pharmaceutical company presents data at cancer research meeting.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Peregrine Pharmaceuticals, Inc., (PPHM) presented new data at the American Association of Cancer Research annual meeting. The presented research included data related to its tumor necrosis therapy...

U.S. FDA issues agreement for Interleukin 21 phase I cancer study.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- ZymoGenetics (ZGEN) has received agreement from the U.S. Food and Drug Administration (FDA) to begin a phase I clinical study with Interleukin 21 (IL-21), a recombinant human protein being developed by...

Study questions reliability of new colon cancer detection method.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- The accuracy of virtual colonoscopy, which provides a computer-generated 3-D view of the colon, varies considerably, depending on the training and methods of the doctors performing it, researchers say....

Validated cancer SNP assays launched using MGB Eclipse Probe Systems.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Epoch Biosciences, Inc., (EBIO), a provider of proprietary products that accelerate genomic analysis, announced that a new panel of assays targeting single nucleotide polymorphisms (SNPs) identified by...

Longevity gene may also predict better outcome for breast cancer patients.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- A gene known to promote longevity in animals has now been discovered to encode a tumor suppressor - a protein that helps prevent cancer, according to a study by a team of scientists from The University...

Interferon-alpha stops the formation of liver cancer in animal models.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Interferon-alpha stops the formation of liver cancer in animal models. According to a study from Japan, "interferon (IFN)-alpha treatment is a common therapy for chronic viral hepatitis and...

Predicting cancer patient survival with gene-expression data.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Cancer specialists often talk about cancer as an umbrella term for more than 200 different diseases, each having unique characteristics. But even these categories are too broad, as the same type of...

Deficiency in alpha 1-antitrypsin increases risk of certain cancers.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Imbalances of neutrophil elastase and alpha1-antitrypsin can increase the risk of developing certain cancers and of cancer progression, researchers say. "Neutrophil elastase and alpha1-antitrypsin...

Proteomic approaches in cancer risk and response assessment described.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Researchers describe proteomic approaches in cancer risk and response assessment in a recent issue of Trends in Molecular Medicine. "Proteomics is more than just a list-generating exercise where...

C-75 maker receives $2.4 million grant for cancer drug research.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- FASgen, Inc., announced receipt of a $2.4 million grant award from the National Cancer Institute for phase II of the study of FASgen's novel compounds (fatty acid synthase inhibitors) for their...

Certain antitumor agents can suppress cutaneous radiation syndrome.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Inhibiting histone deacetylase (HDAC) inhibitors may protect normal skin during radiation therapy, researchers say. "Radiotherapy is an effective treatment for head and neck, skin, anogenital, and...

Company reports advancements in several pipeline programs at AACR meeting.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- ImClone Systems Inc. (IMCL) presented preclinical data highlighting progress made in the development of several pipeline programs at the 95th annual meeting of the American Association for Cancer...

Genetic analyses of angiogenic growth factors generate treatment alternatives.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Genetic analyses of angiogenic growth factors generate treatment alternatives. According to a study from Belgium, "many proliferative diseases, most typically cancer, are driven by uncontrolled...

Matrikines form the basis for new types of antiangiogenesis therapy.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Matrikines form the basis for new types of antiangiogenesis therapy. According to recent research published in the journal Critical Reviews in Oncology/Hematology, "neoangiogenesis, the formation of...

Microwaves regress colorectal tumor tissue in mice.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Microwaves regress colorectal tumor tissue in mice. "The human LoVo and WI-38 cells were exposed to high power non-invasive microwaves. The apoptotic effect of the microwaves on the cells was...

NeoRx acquires cancer compound.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- NeoRx Corp. (NERX) announced that it has acquired from AnorMED, Inc., (AOM) the worldwide exclusive rights, excluding Japan, to develop, manufacture, and commercialize AMD473, a platinum-based...

Phase I healthy volunteer trial of HYB2055 completed.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Hybridon, Inc., (HBY) has completed a phase I trial of HYB2055 in healthy volunteer subjects. In this trial, this drug candidate was safe and biologically active. HYB2055 is a second-generation...

Radiolanthanides show promise in targeted cancer immunotherapy.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- A series of radiolanthanides have significant antitumor effects in mice. "[superscript]149Pm, [superscript]166Ho, and [superscript]177Lu possess a range of half-lives and...

Research shows evidence of synergy and molecular activity of MG98.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Two poster presentations - one demonstrating synergistic usage of MG98 in combination with interferon in renal cancer cells and another disclosing anticancer activity of MG98 as a single agent in...

Studies support Targretin's activity in NSCLC.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Three separate studies by Ligand Pharmaceuticals, Inc., (LGND) scientists presented at the 95th annual meeting of the American Association of Cancer Research (AACR) support enhanced activity of...

Therapy combining cisplatin and overexpressed CAD promotes tumor destruction.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Therapy combining cisplatin and overexpressed CAD promotes tumor destruction. "Recent studies have demonstrated that a caspase-activated deoxyribonuclease (CAD) causes DNA degradation in nuclei...

3M skin cancer treatment final FDA approval delayed.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- 3M Co. April 14, 2004, said it was asked to provide additional safety data on a cream it hopes will be cleared to treat a common form of skin cancer. The St. Paul-based conglomerate said the Food...

Atlanta hospital opens new outpatient center with $2.5 million from AFLAC.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- A $2.5 million gift from AFLAC, Inc., has helped Children's Healthcare of Atlanta open a new outpatient center for children with cancer or blood disorders. Parents and patients were expected to...

DNA vaccines encoding ras epitopes and B7.1 reduced tumor burden in rats.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- DNA vaccines encoding mutated ras epitopes and the costimulatory molecule B7.1 reduced adenocarcinoma tumor burden in rats. "1-Methyl-1-nitrosourea (MNU), a well characterized carcinogen, was used...

Dendritic cell subsets induce antigen-specific cytotoxic T cell responses.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Dendritic cell subsets generated from CD34+ hematopoietic progenitors can be transfected with mRNA and induce antigen-specific cytotoxic T cell responses. "Human dendritic cells (DCs) generated in...

Dendritic cell tumoristatic and tumoricidal activities are distinct.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Distinct mechanisms are involved in tumoristatic and tumoricidal activities of monocyte-derived dendritic cells. According to recent research from Belgium, "Monocyte-derived dendritic cells (DC)...

P-glycoprotein-derived peptides inhibited multidrug resistance of tumors.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Immunization with synthetic P-glycoprotein-derived peptides inhibited multidrug resistance of tumors. "Overexpression of the membrane glycoprotein (P170) represents the most common multidrug...

RNA-transfected cells induce responses against viral and tumor antigens.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- RNA-transfected CD40-activated B cells induce functional T-cell responses against viral and tumor antigen targets. "Vaccination with antigen-presenting cells (APCs) engineered to mimic mechanisms...

Genaissance inks agreements for cardiac tests.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Genaissance Pharmaceuticals, Inc., (GNSC) has signed agreements with the University of Rochester (Minnesota) and the Mayo Foundation for Medical Education and Research, under which Genaissance will...

Bendamustine plus mitoxantrone effective treatment for advanced CLL.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Bendamustine plus mitoxantrone is an effective treatment for advanced chronic lymphocytic leukemia. "The toxicity and efficacy of the combination bendamustine plus mitoxantrone (BM) was evaluated...

Local chemotherapy preserves eyeballs with vitreous seeding.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Local chemotherapy is able to preserve eyeballs that have vitreous seeding. "Retinoblastoma with vitreous seeding has been one of the most challenging conditions for eye-preservation therapy....

gONC increases conformational stability and toxicity for cancer cells.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Glycosylation of onconase increases its conformational stability and toxicity for cancer cells. "Onconase (ONC) is currently in Phase III clinical trials as a cancer chemotherapeutic agent. Despite...

$1.3M NIH grant awarded to study possible viral role in colon cancer.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- The U.S. National Institutes of Health recently awarded Baylor Research Institute a $1.3 million grant to study a common virus suspected to play a role in causing colon cancer. C. Richard "Rick"...

Oral contraceptives increase colon cancer risk.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Oral contraceptives increase colon cancer risk; tubal ligation and abortion decrease risk. "267,400 female textile workers in Shanghai, who were administered a questionnaire at enrollment into a...

Test shows promise for identifying gene alteration indicating cancer.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Testing for DNA changes in stools might provide a new, accurate and less invasive way to screen patients for colorectal cancer, conclude the authors of a research letter. Colorectal cancer is one...

Musk substitution doesn't alter the hepatoprotective actions of Pien Tze Huang.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Musk substitution doesn't alter the hepatoprotective actions of Pien Tze Huang. "Previous studies showed that Pien Tze Huang, a Chinese folk medicine well known for its therapeutic activity in...

Short course of Tibetan yoga improves sleep in cancer patients.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- The first study to look at the use of Tibetan yoga by cancer patients found the combination of movement and meditation led to a significant sleep benefit, say researchers at the University of Texas M.D....

Noninvasive imaging of skin tumors is becoming diagnostically reliable.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- A variety of skin tumors can be diagnosed using noninvasive imaging modalities, researchers say. "In this article, the authors review different approaches to the diagnosis of skin tumors using...

A novel assay quantifies vascular endothelial growth factor-C.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- A novel assay quantifies vascular endothelial growth factor-C. "Lymphangiogenesis plays an important role in several normal and pathological conditions such as wound healing, inflammation or...

Early FAMM diagnosis and prophylaxis decreases neoplastic transformation risk.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Early FAMM diagnosis and prophylaxis decreases risk of neoplastic transformation of melanocytes. "Familial atypical multiple mole melanoma (FAMMM) syndrome is an autosomal dominant disorder with...

Multislice CT angiography can image mesenteric vasculature.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Multislice CT (MSCT) is capable of providing excellent imaging of mesenteric vessels, researchers say. "Due to several distinct advantages over conventional angiography (including minimal...

NMP22 BladderChek reaches milestone.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Matritech (MZT), a developer of proteomics-based diagnostic products for the early detection of cancer, announced that it has reached a significant reimbursement milestone for its NMP22 BladderChek...

Positron-emitting tracers show potential for tumor imaging.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- Positron-emitting tracers show potential for tumor imaging. The "potential of O-[[superscript]11C]methyl-L-tyrosine and O[superscript]18F]fluoromethyl-L-tyrosine as positron-emitting tracers for...

Study documents cost-effectiveness of HPV test in cervical cancer prevention.
May 4, 2004... 2004 MAY 4 - (NewsRx.com & NewsRx.net) -- A new study finds that screening women 30 years of age or older with both a Pap and HPV (human papillomavirus) test reduces cervical cancer incidence by up to 93% and results in a 30% cost savings...